A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer

INTRODUCTION: Cancers presenting at advanced stages inherently have poor prognosis. High grade serous carcinoma (HGSC) is the most common and aggressive form of tubo-ovarian cancer. Clinical tests to accurately diagnose and monitor this condition are lacking. Hence, development of disease-specific t...

Descripción completa

Detalles Bibliográficos
Autores principales: Beirne, James P., Gilmore, Alan, McInerney, Caitríona E., Roddy, Aideen, Glenn McCluggage, W., Harley, Ian J.G., Abdullah Alvi, M., Prise, Kevin M., McArt, Darragh G., Mullan, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260242/
https://www.ncbi.nlm.nih.gov/pubmed/35832628
http://dx.doi.org/10.1016/j.csbj.2022.06.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260242/
https://www.ncbi.nlm.nih.gov/pubmed/35832628
http://dx.doi.org/10.1016/j.csbj.2022.06.016

Ejemplares similares